Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation

Volume: 51, Issue: 6, Pages: 633 - 645
Published: Nov 1, 2021
Abstract
White blood cells activated by either a pathogen or as part of a systemic inflammatory disease are characterized by high energy consumption and are therefore taking up the glucose analogue PET tracer FDG avidly. It is therefore not surprising that a steadily growing body of research and clinical reports now supports the use of FDG PET/CT to diagnose a wide range of patients with non-oncological diseases. However, using FDG PET/CT in patients...
Paper Details
Title
Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation
Published Date
Nov 1, 2021
Volume
51
Issue
6
Pages
633 - 645
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.